Kestra Medical Technologies, Ltd.
KMTS
$24.15
$0.391.64%
NASDAQ
07/31/2025 | 04/30/2025 | 07/31/2024 | |||
---|---|---|---|---|---|
Net Income | 50.39% | -142.01% | 10.77% | ||
Total Depreciation and Amortization | 10.46% | -2.75% | -32.18% | ||
Total Amortization of Deferred Charges | 27.10% | 117.06% | 0.00% | ||
Total Other Non-Cash Items | -89.75% | 3,036.55% | -12.46% | ||
Change in Net Operating Assets | -72.86% | -2,913.01% | -165.35% | ||
Cash from Operations | -10.87% | -28.91% | -17.07% | ||
Capital Expenditure | -2.80% | -97.98% | -67.98% | ||
Sale of Property, Plant, and Equipment | -- | -- | -- | ||
Cash Acquisitions | -- | -- | -- | ||
Divestitures | -- | -- | -- | ||
Other Investing Activities | -86.93% | -- | -45.24% | ||
Cash from Investing | -6.07% | -91.02% | -69.13% | ||
Total Debt Issued | -- | -- | -- | ||
Total Debt Repaid | -- | -- | -- | ||
Issuance of Common Stock | -- | -- | -- | ||
Repurchase of Common Stock | -- | -- | -- | ||
Issuance of Preferred Stock | -- | -- | 727.20% | ||
Repurchase of Preferred Stock | -- | -- | -- | ||
Total Dividends Paid | -- | -- | -- | ||
Other Financing Activities | 45.81% | -2,807.56% | 4,968.56% | ||
Cash from Financing | -100.87% | 180,522.69% | 850.09% | ||
Foreign Exchange rate Adjustments | -- | -- | -- | ||
Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
Net Change in Cash | -119.85% | 912.03% | 1,434.89% | ||